Prescription Drug Policy, 2022 And 2023: The Year In Review And The Year Ahead

Authors

Rachel Sachs, Washington University in St. Louis School of LawFollow

Document Type

News Article

Publication Date

2023

Publication Title

Health Affairs

Abstract

This past year featured many significant developments in the prescription drug policy area, most notably the passage of significant prescription drug pricing reform legislation and a range of developments involving the Food and Drug Administration’s (FDA) accelerated approval program. In this post, I review five key developments from the past year and offer five items to watch for in 2023.

Keywords

Prescription Drug Policy, FDA, Drug Pricing Reform, Food and Drug Administration

Publication Citation

Rachel Sachs, Prescription Drug Policy, 2022 And 2023: The Year In Review And The Year Ahead, Health Affairs (Jan. 9, 2023).

Repository Citation

Sachs, Rachel, "Prescription Drug Policy, 2022 And 2023: The Year In Review And The Year Ahead" (2023). Scholarship@WashULaw. 57.
https://openscholarship.wustl.edu/law_scholarship/57